Department of Radiation Oncology

Comprehensive geometry-based plan quality score for lung VMAT (2026) Brand J, Szkitsak J, Lobão R, Axer BN, Pieper L, Ott O, Haderlein M, et al. Journal article Facile preparation of environmentally relevant nano- and microplastics for hazard assessment and ecotoxicological testing evaluation (2026) Reinosa JJ, Guzmán JC, Fernández-Álvarez M, Katsumiti A, Roldan M, Hierhammer MY, Deloch L, et al. Journal article In Regard to Choi et al (2026) Hannoun-Levi JM, Gutierrez C, Strnad V, Polgar C Journal article Chemoradiation of glioblastoma cells alters expression of activation and immune checkpoint molecules on type 1 and 2 dendritic cells and impacts on subsequent T cell proliferation (2026) Schuster C, Frey B, Fietkau R, Corradini S, Gaipl U, Derer A Journal article Performance analysis of liver segmentation using nn-UNet TotalSegmentator: Focus on atypical livers, pathologies, and variants (2026) Kleiß JM, Arndt S, Sommerfeld L, Schmidt M, Putz F, Graetz T, Stepansky L, et al. Journal article Radiobiology Contributions and Perspectives in Hadron Therapy, With a Focus on Carbon Ions: Report From the Workshop Hadron Therapy for Life, Caen, March 2025 (2026) Haghdoost S, Thariat J, Toma-Dasu I, Frey B, Rodriguez-Lafrasse C, Valable S, Laurent C, et al. Journal article Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group (2026) Beddok A, Appelt AL, Corradini S, Duffton A, Petrianni GM, Tomasik B, Vásquez Osorio E, et al. Journal article Functional Characterization of POLE1 Variant Fibroblasts Reveals Replication Stress and Increased Sensitivity to Genotoxic Stress (2026) Khdeda E, Naumann-Bartsch N, Khdeda N, Cramer G, Hildebrand L, Schiller P, Wagner P, et al. Journal article Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC (2026) Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, et al. Journal article O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial (2026) Grosu AL, Weber WA, Graf E, Mix M, Nestle U, Schimek-Jasch T, Wiehle R, et al. Journal article